Fennec Pharmaceuticals Soars 7.88% Pre-Market on Q2 Earnings and Revenue Beat

FENC Fennec Pharmaceuticals Inc

$10.58 -2.31%

View chart & analysis →

CAVA -3.14% LEGN -15.97% BGSI -1.92%

1. 1Fennec Pharmaceuticals (FENC) shares surged 7.88% in pre-market trading after reporting Q2 earnings and revenue above consensus
2. 2Adjusted EPS came in at $0.05 (consensus $0.02) and revenue at $17.87 million (estimate $16.39 million)
3. 3PEDMARK product sales rose 78% year-over-year, driving adjusted EBITDA to a $2.80 million profit from a prior loss

Source InvestorsHub +1 · View original ↗

Today's 5 AI picks, all free

Nothing hidden: past picks and how they did against the S&P 500.

See today's picks →